Trial Profile

Intravenous Iron Supplement for Iron Deficiency in Patients With Severe Aortic Stenosis: The IIISAS Trial

Status: Active, no longer recruiting

Phase of Trial: Phase II

Latest Information Update: 05 Oct 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Ferric derisomaltose (Primary)
Indications Iron metabolism disorders
Focus Therapeutic Use
Acronyms IIISAS

Most Recent Events

17 May 2022 Primary endpoint has not been met. (Submaximal Exercise Test), as per Results published in the European Journal of Heart Failure
17 May 2022 Results published in the European Journal of Heart Failure
05 Oct 2021 Planned End Date changed from 1 Mar 2022 to 1 Mar 2023.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com